Cargando…
Adjustable Intragastric Balloons: A 12-Month Pilot Trial in Endoscopic Weight Loss Management
Intragastric balloons are associated with (1) early period intolerance, (2) diminished effect within 3–4 months, and (3) bowel obstruction risk mandating removal at 6 months. The introduction of an adjustable balloon could improve comfort and offer greater efficacy. A migration prevention function,...
Autores principales: | Machytka, Evzen, Klvana, Pavel, Kornbluth, Asher, Peikin, Steven, Mathus-Vliegen, Lisbeth E. M., Gostout, Christopher, Lopez-Nava, Gontrand, Shikora, Scott, Brooks, Jeffrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3179587/ https://www.ncbi.nlm.nih.gov/pubmed/21553304 http://dx.doi.org/10.1007/s11695-011-0424-z |
Ejemplares similares
-
Effects of the Intragastric Balloon MedSil® on Weight Loss, Fat Tissue, Lipid Metabolism, and Hormones Involved in Energy Balance
por: Bužga, Marek, et al.
Publicado: (2014) -
Is Endoscopy Really Necessary for Placing Intragastric Balloons?
por: Mathus-Vliegen, Elisabeth M.H.
Publicado: (2017) -
Weight loss with or without intragastric balloon causes divergent effects on ghrelin cell expression
por: Mathus‐Vliegen, Elisabeth, et al.
Publicado: (2021) -
Short-term outcomes of the new intragastric balloon End-Ball(®) for treatment of obesity
por: Buzga, Marek, et al.
Publicado: (2016) -
Effects on physiologic measures of appetite from intragastric balloon and endoscopic sleeve gastroplasty: results of a prospective study
por: Rapaka, Babusai, et al.
Publicado: (2022)